戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  treated with radiotherapy (RT) after breast-conserving surgery.
2 nodes and had completed mastectomy or breast-conserving surgery.
3 changing from radical nephrectomy to nephron-conserving surgery.
4 andard whole-breast irradiation after breast-conserving surgery.
5 ng of TAM and radiotherapy (RT) after breast-conserving surgery.
6  in stage II BC patients treated with breast conserving surgery.
7 .37) were the strongest predictors of breast-conserving surgery.
8 stics were associated with the use of breast-conserving surgery.
9 esponded and 48% underwent successful breast-conserving surgery.
10  was given to 86% of patients who had breast-conserving surgery.
11 e as likely as other women to undergo breast-conserving surgery.
12 ss likely than other women to undergo breast-conserving surgery.
13 ransient effect on the rate of use of breast-conserving surgery.
14                           All had had breast-conserving surgery.
15 influences local recurrence following breast-conserving surgery.
16 fit from neoadjuvant therapy enabling breast-conserving surgery.
17 traoperative margin assessment during breast-conserving surgery.
18 nical application of gGlu-HMRG during breast-conserving surgery.
19 ajority of patients (76.1%) underwent breast-conserving surgery.
20 breast tissue is an important step in breast-conserving surgery.
21 tion of residual cancer tissue during breast-conserving surgery.
22 bmitted for surgery, and 10 underwent breast-conserving surgery.
23 r intraoperative margin assessment in breast-conserving surgeries.
24 tential intraoperative use in guiding breast-conserving surgeries.
25 orbidity for mastectomies (4.0%) than breast conserving surgery (1.6%, P < 0.001).
26 erienced no recurrence, 963 underwent breast-conserving surgery, 263 mastectomy without reconstructio
27 vasive breast cancer, 59.6% underwent breast-conserving surgery, 33.4% underwent unilateral mastectom
28 vasive breast cancer, 59.6% underwent breast-conserving surgery, 33.4% underwent unilateral mastectom
29                                 After breast-conserving surgery, 90% of local recurrences occur withi
30          For those who have undergone breast-conserving surgery, a post-treatment mammogram should be
31          For women who have undergone breast-conserving surgery, a post-treatment mammogram should be
32  omissions of radiation therapy after breast-conserving surgery, adjuvant chemotherapy after resectio
33 00-12.50 Gy/4-5 fractions]) following breast-conserving surgery administered in community-based and a
34 pport the treatment of MO tumors with breast conserving surgery after a detailed clinical evaluation.
35 mpact of tumor biology on the rate of breast-conserving surgery after neoadjuvant chemotherapy has no
36 on, we determined whether the rate of breast-conserving surgery after the legislation was different f
37 rall survival advantage compared with breast-conserving surgery alone.
38 xamined the trend over time in use of breast-conserving surgery among patients in four sites (Connect
39  in both states and the correlates of breast-conserving surgery among women eligible for the procedur
40  to 1.73), but less likely to undergo breast-conserving surgery among women undergoing definitive sur
41 ative whole-breast radiotherapy after breast-conserving surgery and adjuvant endocrine treatment resu
42 e breast cancer who were treated with breast-conserving surgery and adjuvant systemic therapy to unde
43 ults of studies of radiotherapy after breast-conserving surgery and after mastectomy, and an interpre
44  paclitaxel chemotherapy, followed by breast-conserving surgery and axillary lymph node dissection, w
45      These results support the use of breast-conserving surgery and definitive breast irradiation for
46 treatment of DCIS of the breast using breast-conserving surgery and definitive breast irradiation.
47 years (mean, 55.9 years) treated with breast-conserving surgery and irradiation (n = 183) underwent a
48 men have with various providers about breast-conserving surgery and mastectomy.
49 9 through 2011, to determine rates of breast-conserving surgery and pCR after chemotherapy by approxi
50 ast cancers have the highest rates of breast-conserving surgery and pCR after neoadjuvant chemotherap
51  or younger at diagnosis treated with breast-conserving surgery and radiation therapy (> or = 60 Gy)
52 d with LR among patients treated with breast-conserving surgery and radiation therapy.
53 cancer patients who were treated with breast-conserving surgery and radiation were analyzed.
54            We compared the outcome of breast-conserving surgery and radiotherapy in BRCA1/2 mutation
55             For patients treated with breast-conserving surgery and RT, the 5-year cumulative inciden
56           All 5210 patients underwent breast-conserving surgery and SLN dissection.
57 ed with vs without the RT boost after breast-conserving surgery and WBRT.
58 ot both, were permitted), who had had breast-conserving surgery and were receiving adjuvant endocrine
59 an half (56%) of the women who had fertility-conserving surgery and who have been in remission at lea
60           658 women who had undergone breast-conserving surgery and who were receiving adjuvant endoc
61 carcinoma in situ (DCIS) treated with breast-conserving surgery and whole-breast irradiation (WBRT).
62 d, 20% do not receive radiation after breast-conserving surgery, and 30% to 70% of women with lymph n
63 the likelihood that women will choose breast-conserving surgery, and enhances patient knowledge of tr
64 re DCIS (no microinvasion), underwent breast-conserving surgery, and received WBRT with or without th
65 th older age, total mastectomy versus breast-conserving surgery, and reconstructive surgery.
66 f persons undergoing cholecystectomy, breast-conserving surgery, anterior cruciate ligament reconstru
67 mal mortality, recurrence rates after breast-conserving surgery are significant, and half are invasiv
68 e (n = 124), 44% of patients received breast-conserving surgery (BCS) after anastrozole compared with
69 tients with invasive cancer receiving breast-conserving surgery (BCS) and among patients undergoing m
70 adical mastectomy (MRM) compared with breast-conserving surgery (BCS) and radiation therapy (RT).
71 99, demonstrated that tamoxifen after breast-conserving surgery (BCS) and radiotherapy for ductal car
72  breast cancer patients, treated with breast-conserving surgery (BCS) and whole-breast irradiation (W
73 f Health Consensus Statement in 1990, breast-conserving surgery (BCS) became more common while mastec
74  may decrease the reoperation rate in breast-conserving surgery (BCS) compared with rates after surge
75 ists in the use of radiotherapy after breast-conserving surgery (BCS) for ductal carcinoma in situ (D
76 psilateral breast events (IBEs) after breast-conserving surgery (BCS) for ductal carcinoma in situ (D
77 ase inhibitor (AI) treatment promotes breast-conserving surgery (BCS) for estrogen receptor (ER)-posi
78 d for the treatment of DCIS; however, breast-conserving surgery (BCS) has been adopted as the treatme
79 my was performed in 1464 patients and breast-conserving surgery (BCS) in 1395.
80 These 25,000 women included 7300 with breast-conserving surgery (BCS) in trials of radiotherapy (gene
81                                       Breast conserving surgery (BCS) is a recommended treatment for
82               Radiotherapy (RT) after breast-conserving surgery (BCS) is a standard treatment option
83                               PURPOSE Breast-conserving surgery (BCS) is an effective treatment for d
84                              Although breast-conserving surgery (BCS) is often assumed to result in m
85  breast tumor recurrence (IBTR) after breast-conserving surgery (BCS) is relatively high.
86 ase for women with DCIS who underwent breast-conserving surgery (BCS) or mastectomy.
87 cted rates of radiation therapy after breast-conserving surgery (BCS) suggest undertreatment.
88 ume surgeons were more likely to have breast-conserving surgery (BCS) than those managed by low-volum
89                  Guidelines recommend breast-conserving surgery (BCS) with radiation or mastectomy fo
90  CI, 1.00 to 1.85), and have received breast-conserving surgery (BCS) without radiotherapy (v mastect
91 st for early stage breast cancer: (1) breast conserving surgery (BCS), (2) mastectomy with reconstruc
92                       Strategies were breast-conserving surgery (BCS), BCS with 50-Gy radiation (RT)
93 ing NAC, adjuvant chemotherapy (aCT), breast conserving surgery (BCS), bilateral mastectomy (BLM), an
94 he risk of local recurrence following breast-conserving surgery (BCS), even in "low-risk" populations
95 ring partial-breast irradiation after breast-conserving surgery (BCS).
96  have a choice between mastectomy and breast conserving surgery (BCS).
97  wire-guided localization (WGL) after breast conserving surgery (BCS).
98 o not receive radiation therapy after breast-conserving surgery (BCS).
99 teral mastectomy (UM), and (3) CPM vs breast-conserving surgery (BCS).
100 ry treatment option for most women is breast-conserving surgery (BCS).
101 uate residual tumor immediately after breast-conserving surgery (BCS).
102 lly eligible for either mastectomy or breast-conserving surgery (BCS; n = 125).
103 racteristics, treatments (mastectomy, breast-conserving surgery [BCS] with radiation therapy or alone
104                                       Breast-conserving surgery combined with axillary lymph node dis
105                                       Breast-conserving surgery combined with radiation therapy is no
106 he benefit of radiotherapy (RT) after breast-conserving surgery compared with observation.
107 gnosed breast cancer who were offered breast-conserving surgery consented from September 2006 to Nove
108                  To ensure successful breast conserving surgeries, efficient tumour margin resection
109 a cohort of young women who underwent breast-conserving surgery followed by radiotherapy.
110 are comparable to outcomes seen after breast-conserving surgery followed by standard whole-breast irr
111               Radiotherapy (RT) after breast-conserving surgery for early-stage disease has become an
112 regarding the optimal margin width in breast-conserving surgery for invasive breast cancer.
113 d 50 years or older who had undergone breast-conserving surgery for unifocal invasive ductal adenocar
114  women from receiving the benefits of breast-conserving surgery, forcing them to choose a mastectomy
115  database of DCIS patients undergoing breast-conserving surgery from 1978 to 2010.
116                        At a time when breast-conserving surgery has become more widely used, this sha
117  500 patients treated with APBI after breast-conserving surgery have been published.
118               Although mastectomy and breast conserving surgery have low risk for complications, few
119                           The rate of breast-conserving surgery in both states and the correlates of
120                           The rate of breast-conserving surgery in both states was much higher than p
121 atment of breast cancer on the use of breast-conserving surgery in clinical practice.
122                  Although the rate of breast-conserving surgery in each state was higher than expecte
123 r the procedure, nearly 75% underwent breast-conserving surgery in Massachusetts and nearly half did
124                    This method allows axilla-conserving surgery in patients responding well to NST.
125 ing multicatheter brachytherapy after breast-conserving surgery in patients with early breast cancer
126                      In all patients, breast-conserving surgery included complete gross excision of t
127            Hypofractionated WBI after breast conserving surgery increased among women with early-stag
128 tion of all women who were treated by breast-conserving surgery increased, and because this approach
129     Identifying tumour margins during breast-conserving surgeries is a persistent challenge.
130                                       Breast-conserving surgery is a more complex treatment than mast
131                              Although breast-conserving surgery is a standard approach for patients w
132 east cancer, standard treatment after breast-conserving surgery is adjuvant whole-breast radiotherapy
133            Locoregional failure after breast-conserving surgery is associated with increased risk of
134      The surgical margin status after breast-conserving surgery is considered the strongest predictor
135  when invasive local recurrence after breast-conserving surgery is detected.
136               However, its use during tissue-conserving surgery is limited by time-consuming tissue p
137 er, or ductal carcinoma in situ (when breast-conserving surgery is planned) or are pregnant should no
138 ammatory breast cancer, or DCIS (when breast-conserving surgery is planned) or are pregnant should no
139 ing fact about local recurrence after breast-conserving surgery is that most occurs in the area of br
140                                       Breast conserving surgery is the preferred treatment for women
141                                       Tissue-conserving surgery is used increasingly in cancer treatm
142 fter 10 years, but the risk following breast-conserving surgery (lumpectomy) has yet to be determined
143 underwent mastectomy (N = 10,471) and breast conserving surgery (N = 16,517).
144                     For women who had breast-conserving surgery (n = 49 166), the authors examined re
145 Fifty-nine percent of women underwent breast-conserving surgery, of whom 81% received radiation thera
146 n undergoing an inappropriate form of breast-conserving surgery (omission of radiotherapy, axillary n
147 through 79 years of age who underwent breast-conserving surgery or mastectomy for local or regional b
148 on aid were 25% more likely to choose breast-conserving surgery over mastectomy (risk ratio, 1.25; 95
149 no more likely than others to undergo breast-conserving surgery (P >.2), but these women were more sa
150 DeltaBF cutoff = -30%; P = 0.03), non-breast-conserving surgery (P = 0.04), and the absence of a path
151 wer mortality than that achieved with breast-conserving surgery plus radiation.
152 ernia, and 0.8% and 0.8% after 42,489 breast-conserving surgery procedures.
153  surgical therapy, radiotherapy after breast-conserving surgery, radiation therapy after mastectomy,
154  women with breast cancer who undergo breast-conserving surgery receive whole-breast irradiation.
155 randomized trials, radiotherapy after breast-conserving surgery reduced mortality from both breast ca
156  Medicare coverage had lower rates of breast-conserving surgery than other women (43.2% vs. 49.2%; ad
157 ely to undergo standard therapy after breast-conserving surgery than other women.
158 urgically treated patients (including breast-conserving surgery), the CPM rate increased by 148% from
159 t DCIS (excluding patients undergoing breast-conserving surgery), the CPM rate increased by 188% from
160 </= 3 cm were randomly assigned after breast-conserving surgery to 3D-CRT APBI (38.5 Gy in 10 fractio
161 our to avoid mastectomy, and to allow breast-conserving surgery to be done.
162 al trends between patients undergoing breast-conserving surgery, unilateral mastectomy, and CPM.
163 al trends between patients undergoing breast-conserving surgery, unilateral mastectomy, and CPM.
164  radiation); axillary dissection; and breast-conserving surgery versus mastectomy among women undergo
165                            Receipt of breast-conserving surgery versus mastectomy.
166 erall rate of radiation therapy after breast-conserving surgery was 80% in the quality improvement pr
167 bservational data, radiotherapy after breast-conserving surgery was associated with much larger morta
168                                       Breast-conserving surgery was more frequently performed at teac
169                    RT was required if breast-conserving surgery was performed but was elective after
170 of patients undergoing mastectomy and breast conserving surgery was performed from the National Surgi
171                                       Breast-conserving surgery was possible in 66.6% of the patients
172                                       Breast-conserving surgery was recommended by surgeons and attem
173                           The rate of breast-conserving surgery was up to 8.7 percent higher than exp
174                          The rates of breast-conserving surgery were 66.7%, 57.9%, and 68.9% in arms
175 ductal carcinoma in situ treated with breast-conserving surgery were centrally randomised to either w
176 ve ductal breast carcinoma undergoing breast-conserving surgery were enrolled from 28 centres in nine
177  primary breast cancer ineligible for breast-conserving surgery were randomly assigned to 4 months of
178                              Rates of breast-conserving surgery were significantly higher in patients
179                              Rates of breast-conserving surgery were similar between the two groups (
180 s operable and increases the rates of breast-conserving surgery, while achieving similar long-term cl
181 oximately 3% of patients treated with breast-conserving surgery will have an in-breast local recurren
182 published world medical literature on breast-conserving surgery with and without postoperative irradi
183 tomy with axillary node dissection or breast-conserving surgery with axillary node dissection and rad
184 ges I or II breast cancer, excised by breast conserving surgery with negative margins, were eligible
185 om patients who had been treated with breast-conserving surgery with or without postoperative radiati
186                         Compared with breast-conserving surgery with radiation (10-year mortality, 16
187  between 1998 and 2007, who underwent breast-conserving surgery with radiation (breast-conserving the
188  between 1998 and 2007, who underwent breast-conserving surgery with radiation (breast-conserving the
189  CI, 1.02 to 1.73) more likely to get breast-conserving surgery with radiation than other types of tr
190 d on National Guidelines as receiving breast-conserving surgery with radiation therapy and axillary n
191  of definitive surgery (mastectomy or breast-conserving surgery with radiation v breast-conserving su
192 ed that their surgeon did not discuss breast-conserving surgery with them.
193 RO) guideline on surgical margins for breast-conserving surgery with whole-breast irradiation in stag
194 atic SLNs who are planning to undergo breast-conserving surgery with whole-breast radiotherapy should
195 o metastatic SLNs planning to undergo breast-conserving surgery with whole-breast radiotherapy should
196 carcinoma in situ (DCIS) treated with breast-conserving surgery without adjuvant radiation therapy (R
197 s lower (3.7% vs 5.0%; P < .001), and breast-conserving surgery without other treatment was more freq
198 t-conserving surgery with radiation v breast-conserving surgery without radiation); axillary dissecti
199                   Among women who had breast-conserving surgery, women with SSDI and Medicare coverag

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top